Key Insights

Highlights

Treatment Research

2 treatments under study, led by Ucmscs

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Unknown1

Clinical Trials (1)

Research Network

Common Treatments

  • Ucmscs1
  • Normal Saline1

Active Sponsors

  • China Medical University Hospital1

Top Investigators

Related Conditions

  • No Severe Ivh Neither Cystic Pvl1
  • Severe Bpd That Conventional Therapies Has Failed1
  • Bronchopulmonary Dysplasia1
  • Extremely Premature Infants1

Activity Timeline